Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France

Huber M, Huber B. Innovation in oncology drug development. J Oncol. 2019;2019:9683016. https://doi.org/10.1155/2019/9683016.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Cao Z, Prettner K, Kuhn M, Yang J, Jiao L, et al. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9:465–72. https://doi.org/10.1001/jamaoncol.2022.7826.

Article  PubMed  PubMed Central  Google Scholar 

Kim H, Goodall S, Liew D. Health technology assessment challenges in oncology: 20 years of value in health. Value Health. 2019;22:593–600. https://doi.org/10.1016/j.jval.2019.01.001.

Article  PubMed  Google Scholar 

Winn AN, Ekwueme DU, Guy GP Jr, Neumann PJ. Cost-utility analysis of cancer prevention, treatment, and control: a systematic review. Am J Prev Med. 2016;50:241–8. https://doi.org/10.1016/j.amepre.2015.08.009.

Article  PubMed  Google Scholar 

Higgins AM, Harris AH. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations. Crit Care Clin. 2012;28(11–24):v. https://doi.org/10.1016/j.ccc.2011.10.002.

Article  PubMed  Google Scholar 

Robinson R. Cost-utility analysis. BMJ. 1993;307:859–62. https://doi.org/10.1136/bmj.307.6908.859.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roudijk B, Donders ART, Stalmeier PFM. Setting dead at zero: applying scale properties to the QALY model. Med Decis Making. 2018;38:627–34. https://doi.org/10.1177/0272989X18765184.

Article  PubMed  PubMed Central  Google Scholar 

Rowen D, Azzabi Zouraq I, Chevrou-Severac H, van Hout B. International regulations and recommendations for utility data for health technology assessment. Pharmacoeconomics. 2017;35:11–9. https://doi.org/10.1007/s40273-017-0544-y.

Article  PubMed  Google Scholar 

Haute Autorité de Santé. Indicateurs pour l'amélioration de la qualité et de la sécurité des soins: aide à l’utilisation de questionnaires patients de mesure des résultats de soins dans le cadre de l’expérimentation « Episode de soins ». Paris; September 2019.

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36. https://doi.org/10.1007/s11136-011-9903-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ware JE, Jr. SF-36 Health survey: manual and interpretation guide. Boston; 1993.

Brazier J, Ara R, Rowen D, Chevrou-Severac H. A review of generic preference-based measures for use in cost-effectiveness models. Pharmacoeconomics. 2017;35:21–31. https://doi.org/10.1007/s40273-017-0545-x.

Article  PubMed  Google Scholar 

Gibson AEJ, Longworth L, Bennett B, Pickard AS, Shaw JW. Assessing the content validity of preference-based measures in cancer. Value Health. 2024;27:70–8. https://doi.org/10.1016/j.jval.2023.10.006.

Article  PubMed  Google Scholar 

Noel CW, Keshavarzi S, Forner D, Stephens RF, Watson E, Monteiro E, et al. Construct validity of the EuroQoL-5 dimension and the health utilities index in head and neck cancer. Otolaryngol Head Neck Surg. 2022;166:877–85. https://doi.org/10.1177/01945998211030173.

Article  PubMed  Google Scholar 

van Dongen-Leunis A, Redekop WK, Uyl-de Groot CA. Which questionnaire should be used to measure quality-of-life utilities in patients with acute leukemia? An evaluation of the validity and interpretability of the EQ-5D-5L and preference-based questionnaires derived from the EORTC QLQ-C30. Value Health. 2016;19:834–43. https://doi.org/10.1016/j.jval.2016.05.008.

Article  PubMed  Google Scholar 

King MT, Costa DSJ, Aaronson NK, Brazier JE, Cella DF, Fayers PM, et al. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Qual Life Res. 2016;25:625–36. https://doi.org/10.1007/s11136-015-1217-y.

Article  CAS  PubMed  Google Scholar 

King MT, Viney R, Simon Pickard A, Rowen D, Aaronson NK, Brazier JE, et al. Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. Pharmacoeconomics. 2018;36:225–38. https://doi.org/10.1007/s40273-017-0582-5.

Article  PubMed  Google Scholar 

Norman R, Kemmler G, Viney R, Pickard AS, Gamper E, Holzner B, et al. Order of presentation of dimensions does not systematically bias utility weights from a discrete choice experiment. Value Health. 2016;19:1033–8. https://doi.org/10.1016/j.jval.2016.07.003.

Article  PubMed  Google Scholar 

Gamper E-M, Holzner B, King MT, Norman R, Viney R, Nerich V, Kemmler G. Test-retest reliability of discrete choice experiment for valuations of QLU-C10D health states. Value Health. 2018;21:958–66. https://doi.org/10.1016/j.jval.2017.11.012.

Article  PubMed  Google Scholar 

Gamper E-M, King MT, Norman R, Loth FLC, Holzner B, Kemmler G. The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weights. J Patient Rep Outcomes. 2022;6:42. https://doi.org/10.1186/s41687-022-00430-5.

Article  PubMed  PubMed Central  Google Scholar 

Seyringer S, Pilz MJ, Jansen F, Büttner M, King MT, Norman R, et al. Cancer-specific utility instrument for health economic evaluations: a synopsis of the EORTC QLU-C10D user manual and current validity evidence. Eur J Cancer. 2025;217: 115235. https://doi.org/10.1016/j.ejca.2025.115235.

Article  PubMed  Google Scholar 

Giesinger JM, Efficace F, Aaronson N, Calvert M, Kyte D, Cottone F, et al. Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: a systematic review. Value Health. 2021;24:585–91. https://doi.org/10.1016/j.jval.2020.11.004.

Article  PubMed  Google Scholar 

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. https://doi.org/10.1093/jnci/85.5.365.

Article  CAS  PubMed  Google Scholar 

Gamper EM, King MT, Norman R, Efficace F, Cottone F, Holzner B, Kemmler G. EORTC QLU-C10D value sets for Austria, Italy, and Poland. Qual Life Res. 2020;29:2485–95. https://doi.org/10.1007/s11136-020-02536-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jansen F, Verdonck-de Leeuw IM, Gamper E, Norman R, Holzner B, King M, Kemmler G. Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D. Qual Life Res. 2021;30:2009–19. https://doi.org/10.1007/s11136-021-02767-8.

Article  PubMed  PubMed Central  Google Scholar 

Kemmler G, Gamper E, Nerich V, Norman R, Viney R, Holzner B, King M. German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Qual Life Res. 2019;28:3197–211. https://doi.org/10.1007/s11136-019-02283-w.

Article  PubMed  PubMed Central  Google Scholar 

McTaggart-Cowan H, King MT, Norman R, Costa DSJ, Pickard AS, Regier DA, et al. The EORTC QLU-C10D: the Canadian valuation study and algorithm to derive cancer-specific utilities from the EORTC QLQ-C30. MDM Policy Pract. 2019;4:2381468319842532. https://doi.org/10.1177/2381468319842532.

Article  PubMed  PubMed Central  Google Scholar 

Nerich V, Gamper EM, Norman R, King M, Holzner B, Viney R, Kemmler G. French value-set of the QLU-C10D, a cancer-specific utility measure derived from the QLQ-C30. Appl Health Econ Health Policy. 2021;19:191–202. https://doi.org/10.1007/s40258-020-00598-1.

Article  PubMed  Google Scholar 

Norman R, Mercieca-Bebber R, Rowen D, Brazier JE, Cella D, Pickard AS, et al. U.K. utility weights for the EORTC QLU-C10D. Health Econ. 2019;28:1385–401. https://doi.org/10.1002/hec.3950.

Article  PubMed  Google Scholar 

Revicki DA, King MT, Viney R, Pickard AS, Mercieca-Bebber R, Shaw JW, et al. United States utility algorithm for the EORTC QLU-C10D, a multiattribute utility instrument based on a cancer-specific quality-of-life instrument. Med Decis Making. 2021;41:485–501. https://doi.org/10.1177/0272989X211003569.

Article  PubMed  Google Scholar 

Comments (0)

No login
gif